Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: Systematic review and meta-analysis
Jesse D. Kosiba, Stephen A. Maisto, Joseph W. Ditre
Social Science & Medicine (2019) Vol. 233, pp. 181-192
Closed Access | Times Cited: 179

Showing 1-25 of 179 citing articles:

Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
Jerome Sarris, Justin Sinclair, Diana Karamacoska, et al.
BMC Psychiatry (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 201
Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals
Christopher A. Legare, Wesley M. Raup‐Konsavage, Kent E. Vrana
Pharmacology (2022) Vol. 107, Iss. 3-4, pp. 131-149
Open Access | Times Cited: 167
Anxiety, depression and stress during the COVID-19 pandemic: Results from a cross-sectional survey
Jasmine Turna, Jasmine Zhang, Nina Lamberti, et al.
Journal of Psychiatric Research (2021) Vol. 137, pp. 96-103
Open Access | Times Cited: 121
Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process
Arun Bhaskar, Alan Bell, Michael Boivin, et al.
Journal of Cannabis Research (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 115
Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties
Lara Sharpe, Justin Sinclair, Andrew Kramer, et al.
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 90
Predicting Self-Medication with Cannabis in Young Adults with Hazardous Cannabis Use
Dorothy Wallis, J. Douglas Coatsworth, Jeremy Mennis, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 3, pp. 1850-1850
Open Access | Times Cited: 54
Effect of Inhaled Cannabis for Pain in Adults With Sickle Cell Disease
Donald I. Abrams, Paul Couey, Niharika Dixit, et al.
JAMA Network Open (2020) Vol. 3, Iss. 7, pp. e2010874-e2010874
Open Access | Times Cited: 57
A review investigating the relationship between cannabis use and adolescent cognitive functioning
Elena Cyrus, Makella Coudray, Sandra Kiplagat, et al.
Current Opinion in Psychology (2020) Vol. 38, pp. 38-48
Open Access | Times Cited: 54
Medical cannabis use in the United States: a retrospective database study
V. Kishan Mahabir, Jamil J. Merchant, Christopher J. Smith, et al.
Journal of Cannabis Research (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 53
“Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations
Caroline A. MacCallum, Lindsay A. Lo, Michael Boivin
European Journal of Internal Medicine (2021) Vol. 89, pp. 10-18
Open Access | Times Cited: 52
Association of Depression With Past-Month Cannabis Use Among US Adults Aged 20 to 59 Years, 2005 to 2016
Lauren Gorfinkel, Malki Stohl, Deborah S. Hasin
JAMA Network Open (2020) Vol. 3, Iss. 8, pp. e2013802-e2013802
Open Access | Times Cited: 51
The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review
Maryam Sorkhou, Rachel H. Bedder, Tony P. George
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 44
Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence
Lauren Kuhns, Emese Kroon, Karis Colyer‐Patel, et al.
Psychopharmacology (2021) Vol. 239, Iss. 5, pp. 1231-1249
Open Access | Times Cited: 43
Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample
Sinikka L. Kvamme, Michael Mulbjerg Pedersen, Kristine Rømer Thomsen, et al.
Harm Reduction Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 41
Cannabis use prevalence, patterns, and reasons for use among patients with cancer and survivors in a state without legal cannabis access
Erin A. McClure, Kyle J. Walters, Rachel L. Tomko, et al.
Supportive Care in Cancer (2023) Vol. 31, Iss. 7
Closed Access | Times Cited: 20
Multinational Association of Supportive Care in Cancer (MASCC) guidelines: cannabis for psychological symptoms including insomnia, anxiety, and depression
Giulia De Feo, Amy A. Case, Gregory B. Crawford, et al.
Supportive Care in Cancer (2023) Vol. 31, Iss. 3
Closed Access | Times Cited: 18
Cannabis use and mood disorders: a systematic review
Maryam Sorkhou, Eliza L Dent, Tony P. George
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 6
Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany
Natalia Szejko, Eva Becher, Florian Heimann, et al.
Pharmacopsychiatry (2024) Vol. 57, Iss. 03, pp. 133-140
Open Access | Times Cited: 6
Select Minor Cannabinoids from Cannabis sativa Are Cannabimimetic and Antinociceptive in a Mouse Model of Chronic Neuropathic Pain
Abigail M. Schwarz, Dea Kobeci, Jessica Mancuso, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 391, Iss. 2, pp. 214-221
Open Access | Times Cited: 5
Cannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humans
Verity Chadwick, Cathrin Rohleder, Dagmar Koethe, et al.
Current Opinion in Psychiatry (2019) Vol. 33, Iss. 1, pp. 20-42
Closed Access | Times Cited: 53
A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019
Sebastian Jugl, Aimalohi Okpeku, Brianna Costales, et al.
Medical Cannabis and Cannabinoids (2021) Vol. 4, Iss. 1, pp. 21-42
Open Access | Times Cited: 39
Cannabis chemistry, post-harvest processing methods and secondary metabolite profiling: A review
Philip Wiredu Addo, Vincent Desaulniers Brousseau, Victorio Morello, et al.
Industrial Crops and Products (2021) Vol. 170, pp. 113743-113743
Closed Access | Times Cited: 38
Effects of Cannabis in Parkinson’s Disease: A Systematic Review and Meta-Analysis
Berzenn Urbi, Joel Corbett, Ian Hughes, et al.
Journal of Parkinson s Disease (2021) Vol. 12, Iss. 2, pp. 495-508
Open Access | Times Cited: 37
Cannabis Legalization and the Decline of Cannabis Use Disorder (CUD) Treatment Utilization in the US
Jeremy Mennis, Gerald J. Stahler, Michael J. Mason
Current Addiction Reports (2023) Vol. 10, Iss. 1, pp. 38-51
Closed Access | Times Cited: 15
The evolving culture of medical cannabis in Canada for the management of chronic pain
Hance Clarke, Mary‐Ann Fitzcharles
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top